Concepedia

Publication | Open Access

Cholecalciferol in relapsing-remitting MS: A randomized clinical trial (CHOLINE)

95

Citations

13

References

2019

Year

Abstract

This study provides Class II evidence that for patients with RRMS and low serum 25OHD, cholecalciferol did not significantly affect ARRs.

References

YearCitations

Page 1